Growth Metrics

Cardiff Lexington (CDIX) Asset Writedowns and Impairment (2018 - 2024)

Cardiff Lexington posted quarterly Asset Writedowns and Impairment of $266000.0 for Q4 2024, up 293.15% year-on-year from $67659.2 in Q1 2024, and down 78.58% on a QoQ basis from $1.2 million in Q2 2024.

Cardiff Lexington (CDIX) has 4 years of Asset Writedowns and Impairment data on file, last reported at $266000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment rose 293.15% year-over-year to $266000.0; the trailing twelve-month figure through Dec 2024 stood at $1.5 million (up 1040.01% YoY), and the FY2024 full-year result was $266000.0, up 101.09% from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 stood at $266000.0, down from $1.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.2 million in Q2 2024 and bottomed at -$137719.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Cardiff Lexington - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 266,000.00
Dec 31, 2024 266,000.00
Jun 30, 2024 1.24 Mn
Jun 30, 2024 1.24 Mn
Dec 31, 2023 -137,719.00
Dec 31, 2023 -137,719.00
Mar 31, 2023 270,000.00
Mar 31, 2023 270,000.00
Dec 31, 2019 -16,338.00
Dec 31, 2019 -16,338.00
Sep 30, 2019 -68,049.00
Sep 30, 2019 -68,049.00
Dec 31, 2018 -2.09 Mn
Dec 31, 2018 -2.09 Mn
Sep 30, 2018 2.09 Mn
Sep 30, 2018 2.09 Mn